NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
Key Details
- 1NIH total investment in the AI4AD project now totals $30.7 million, with a new $12.6 million award supporting the next phase (AI4AD2).
- 2AI4AD2 unites 10 investigators and 23 co-investigators from 10 institutions.
- 3The project integrates whole-genome sequencing, brain imaging, cognitive tests, and biological data from over 58,000 participants across 57 cohorts.
- 4New 'genomic language models' will analyze genomic sequences for disease-associated DNA changes.
- 5AI tools developed previously demonstrated >90% accuracy detecting Alzheimer's markers from over 80,000 brain scans.
- 6The initiative also focuses on inclusive, multi-ancestry research and genome-guided drug discovery.
Why It Matters
This large-scale effort could redefine Alzheimer's diagnosis and treatment by combining AI-powered brain imaging analysis with genomics, enabling precision medicine approaches. It also addresses diversity and reproducibility issues in neuroimaging and biomarker AI research.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.